RecallRadar

FDA Drug recall D-1842-2019

Simvastatin Tablets, USP 40 mg

On 2019-09-04 the FDA classified a Class III recall of Simvastatin Tablets, USP 40 mg by Aurobindo Pharma Usa, citing labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1842-2019
ClassificationClass III
Statusterminated
Initiated2019-07-29
Published2019-09-04
Last updated2026-09-13 11:52 UTC
CompanyAurobindo Pharma Usa
DistributionUS

Product

Simvastatin Tablets, USP 40 mg. Rx Only 1000 Count Bottles Manufactured by: Aurolife Pharma LLC Dayton NJ 08810 Manufactured for: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 65862-053-99

Reason

Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B

Identifiers

ndc65862-050-30
ndc65862-050-45
ndc65862-050-90
ndc65862-050-01
ndc65862-050-00
ndc65862-050-99
ndc65862-050-26
ndc65862-051-30
ndc65862-051-45
ndc65862-051-90
ndc65862-051-01
ndc65862-051-00
ndc65862-051-99
ndc65862-051-26
ndc65862-052-30
ndc65862-052-45
ndc65862-052-90
ndc65862-052-01
ndc65862-052-00
ndc65862-052-99
ndc65862-052-26
ndc65862-053-30
ndc65862-053-45
ndc65862-053-90
ndc65862-053-01
ndc65862-053-00
ndc65862-053-99
ndc65862-053-22
ndc65862-054-30
ndc65862-054-45
ndc65862-054-90
ndc65862-054-00
ndc65862-054-99
ndc65862-054-39
code_info05318054B, exp 3/2021

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1842-2019%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.